Health Condition 1: L501- Idiopathic urticaria
Conditions
Interventions
Intervention1: Narrow band Ultraviolet B phototherapy along with Antihistamine: NBUVB Phototherapy will be given using the Dermaindia Spiegel series Whole body NBUVB Phototherapy unit (311 nm).Phototh
Sponsors
Amritha R Bhat
Eligibility
Inclusion criteria
Inclusion criteria: Patients of Chronic spontaneous urticaria of age 18 and above after getting informed consent
Exclusion criteria
Exclusion criteria: Pregnant or lactating women History of photosensitivity disorders or claustrophobia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the change in Urticaria Activity Score (UAS7) and Urticaria Control Test (UCT) from baseline between the two groups.Timepoint: To compare the change in Urticaria Activity Score (UAS7) and Urticaria Control Test (UCT) from baseline between the two groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess remission rates at 12 weeks. To evaluate quality of life using Dermatology Life Quality Index (DLQI). To monitor reduction in antihistamine usage. Timepoint: DLQI score at weeks 8 and 12 UAS7 at the end of 12 weeks | — |
Countries
India
Contacts
Public ContactDr Amritha R Bhat
Indira Gandhi Medical College and Research Institute
Outcome results
None listed